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1. Introduction 
Brandt et al. [ 1,2] made the original observation 
that liver and muscle extracts contain heat-stable, 
trypsin-labile proteins which inhibit phosphorylase 
phosphatase. The regulatory role of these heat-stable 
proteins in the control of phosphatase activity was 
accentuated when two heat-stable inhibitors, termed 
inhibitor-l and -2 were discovered and the inhibitory 
capacity of inhibitor-l demonstrated to depend upon 
its phosphorylation by the cyclic AMP-dependent 
protein kinase [3,4]. Heat-stable phosphatase inhibi- 
tors have since been identified in a variety of animals 
and tissues [S-l 0] and purified to homogeneity from 
rabbit muscle (inhibitor-l , -2) [8 ,101 and rabbit liver 
[7]. The implication of inhibitor-l in the hormonal 
regulation of glycogen metabolism has been clearly 
demonstrated [ll-131. 
We have reported the purification and character- 
isation of an ATP-Mgdependent protein phosphatase 
system from rabbit muscle [14-191: an inactive mul- 
tifunctional protein phosphatase (FC) was shown to 
be activated by another protein factor (FA) in the 
presence of ATP-Mg ions (without phosphorylation). 
This report provides evidence that purified inhibitor-2 
preparations [lo] have the capacity to reverse the F, 
and ATP-Mg-mediated activation. 
2. Materials and methods 
Most materials and methods have been described 
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in [ 14,171. The ATP-Mgdependent phosphatase activ- 
ity was commonly measured after a 10 min preincu- 
bation at 30°C with the activating protein FA, 0.1 mM 
ATP and 0.5 mM Mg-acetate. One unit of phosphatase 
activity releases 1 nM [32P]phosphate/min at 30°C 
from 32P-labelled phosphorylase a (2 mg/ml). 
Inhibitor-2 was purified to homogeneity from rab- 
bit muscle according to [lo]: specific activity was 
80 000 U/mg . One unit of inhibitor-2 measured accord- 
ing to [lo], decreased the activity of the ATP-Mg- 
dependent phosphatase [141 by 50%. The ATP-Mg- 
dependent phosphatase and protein phosphatase-1 
have the same sensitivity towards :he heat-stable pro- 
tein inhibitors [ 191. 
Purified rabbit muscle inhibitor-l (phosphorylated) 
was a generous gift of Dr P. Cohen, University of 
Dundee. 
Rabbit muscle protein phosphatase, F, (10 000 
U/mg) and the activating protein FA (5000 U/mg) 
were purified according to [l] and [2], respectively. 
TPCK-treated trypsin was purchased from 
Worthington Biochemical Co. (England) and soybean 
trypsin inhibitor from Sigma Chemical Co. (USA). 
3. Results and discussion 
3 .l . Preparation of tlypsin-treated activated Fc- 
enzyme 
About 20 000 U F, (2 mg protein) were fully 
activated by FA and ATP-Mg and subsequently incu- 
bated at 30°C for 5 min with 0.2 mg TPCK-treated 
trypsin/ml. The proteolysis was stopped by the addi- 
tion of 1 .O mg soybean trypsin inhibitor/ml and the 
‘irreversibly activated FCenzyme’ applied to a 
(1 X 1 cm) polylysine-Sepharose 4B column equili- 
brated in a 20 mM Tris, 0.5 mM dithiothreitol pH 7 
1 
Volume 127, number 1 FEBS LETTERS May 1981 
buffer. F,, ATP-Mg, the [trypsin-trypsin inhibitor] 
complex and residual free trypsm inhibitor could be 
completely washed out from the resin with a 0.2 M 
NaCl rinse and the phosphatase activity was subse- 
quently eluted with 0.5 M NaCl in the same buffer, as 
in [ 14 .17 ,181. The pooled fractions were concentrated 
by dialysis against 20 mM Tris. 0.5 mM dithiothreitol, 
50% glycerol (pH 7) for 1 h. The phosphatase activity 
measured with or without an F, and ATP-Mg preincu- 
bation was the same (>9000 U/mg protein). indicating 
that the FCenzyme was still fully,activated. 
3 2. Itlhibitor-2 mediated corwersiorl to the inactive 
A TP-Mgilependent erlzyme form (Fc) 
When an appropriately diluted sample of the tryp- 
sin-treated, activated FC (-3 nM or 2 U/ml) was incu- 
bated at 30°C for up to 40 min, no reversal to the 
inactive FC-form was noticed, as reported [ 17,181 
when activated F, was used without trypsin treatment. 
The phosphatase activity at t = 0 was taken as 100% 
(fig.1). When 0.1-0.4 pg inhibitor-2/ml(5-20 nM or 
8-32 U/ml) was included in the preincubation, a time- 
dependent conversion to the inactive Fcenzyme was 
observed (fig.1). It should be mentioned however that 
when an excess of inhibitor-2 was added to the preincu- 
bation mixture, we were not able to fully reactivate 
the phosphatase to the original level by an F, and 
ATP-Mg preincubation. The time dependency of the 
inhibitor-‘-mediated inhibition has also been observed 
using partially purified preparations [20] of the 
glycogen-bound phosphatase (500 U/mg) isolated from 
dog liver (not shown). 
When phosphorylated inhibitor-l was used instead, 
we observed a concentration-dependent decrease of 
the phosphatase activity, which was instantaneous 
(not time-dependent): no reactivation of the enzymic 
activity by F, and ATP-Mg was possible (not shown). 
These results suggest hat whereas phosphorylated 
inhibitor-l shows all the characteristics of a real inhib- 
itory protein, whose effect can be abolished by dilu- 
tion [9], the inhibitor-2 protein can decrease the 
enzymic activity by converting the active phosphatase 
to the inactive ATP-Mgdependent F,-form. The effect 
of inhibitor-2 could not be reversed by dilution. A 
detailed kinetic analysis of the mode of action of 
inhibitor-l has been made using a highly purified prep- 
aration of a multifunctional protein phosphatase [9] : 
the inhibition was of a simple non-competitive nature. 
The inhibition by inhibitor-2 has been described as 
mixed non-competitive [IO]. 
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Fig.1. Timedependent reversal of the FC-actlvation after 
trypsin-treatment and polylysine-Sepharose 4B chromatog- 
raphy by preincubation at 30°C in the absence co,*) or pres- 
ence of 0.1 (a,~), 0.2 (0,m) or 0.4 (s,*) tig inhibitor-2/ml, 
respectively. At the various time points, the preparations were 
assayed for total phosphatase activity (after a preincubation 
with FA and ATP-Mg) and for activated FC (without (o,A,~,*) 
an additional preincubation with FA and ATP-Mg) (o,A,o,x). 
Whereas inhibitor-l has been clearly implicated in 
the hormonal control of glycogen metabolism. by vir- 
tue of the regulation ofits activity by the cyclic AMP- 
dependent protein kinase [ 1 l-l 31 no specific role 
has been attributed to inhibitor-2 in the regulation of 
the phosphatase activity. The concentration of a heat- 
stable protein inhibitor of phosphatase activity has 
been shown to vary with the diabetic state of rat livers, 
and to be under insulin control [21]. However the 
exact nature of the inhibitor involved in these experi- 
ments was not specified. 
4. Conclusions 
The mechanism of interconversion between the 
inactive ATP-Mgdependent phosphatase (Fc) and the 
spontaneously active enzyme has been explained as 
being the result of a metal activation [ 17,181. A phos- 
phate incorporation into F, was excluded although 
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the activating protein (FA) has been shown to exhibit 
synthase kinase activity. This report shows that the 
reversal of this activation can be promoted by the heat- 
stable phosphatase inhibitor-2. This confirms the non- 
covalent nature of the phosphatase interconversion 
and provides evidence for a specific role of inhibitor-2 
in the inactivation of the phosphatase, The irreversi- 
bility of the F, activation after trypsin treatment may 
have been the result of the proteolytic destruction of 
the inactivating protein. FC has been reported to con- 
tain heat-stable phosphatase inhibitory activity [ 171. 
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